Publication Name	World Journal of Clinical Cases
Manuscript ID	38401
Country	China

Category	Medicine, Research & Experimental
Manuscript Type	Case Report
Article Title	Achievable complete remission of advanced non-small-cell lung cancer: Case report and review of the literature
Manuscript Source	Invited Manuscript
All Author List	Ning-Ning Yang, Fei Xiong, Qing He and Yong-Song Guan
Funding Agency and Grant Number
Corresponding Author	Yong-Song Guan, MD, PhD, Professor, Department of Oncology, West China Hospital of Sichuan University, 37 Guoxuexiang Street, Chengdu 610041, Sichuan Province, China. yongsongguan@yahoo.com
Key Words	Tyrosine kinase inhibitor; Bronchial artery infusion; Icotinib hydrochloride; Epidermal growth factor receptor; Advanced non-small-cell lung cancer
Core Tip	Few patients can undergo surgery for tre­atment of non-small-cell lung cancer because of ad­vanced disease or poor pulmonary function. Combin­ation of bronchial artery infusion of anti-cancer agents and oral targeted drug is safe, tolerable, and effective for patients with epidermal growth factor receptor mutation-positive non-small-cell lung cancer (NSCLC). Complete remission of advanced NSCLC can be achieved by this combination therapy.
Citation	Yang NN, Xiong F, He Q, Guan YS. Achievable complete rem­ission of advanced non-small-cell lung cancer: Case report and review of the literature. World J Clin Cases 2018; 6(7): 150-155

Received	2018-02-22 15:15
Peer-Review Started	2018-02-22 18:22
To Make the First Decision	2018-03-09 07:33
Return for Revision	2018-03-12 02:11
Revised	2018-03-15 11:23
Second Decision	2018-04-19 00:13
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2018-04-22 17:49
Articles in Press	2018-04-22 17:49
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2018-06-01 00:23

ISSN	2307-8960 (online)
Open Access	This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2018. Published by Baishideng Publishing Group Inc. All rights reserved.
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com